Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy. (Q48155026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

S Culine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M Fabbro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

G Romieu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

D Cupissol

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

H Pujol

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

569-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

Cancer of unknown primary site

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Treatment of patients with cancer of an unknown primary site

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026478009050

7 January 2021

Identifiers

DOI

10.1023/A:1026478009050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416007%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference